$LUCY
Innovative Eyewear Inc Stock $lucy

$lucy Overview Financials Valuation SEC Filings Company Website

2023 Q1 Form 10-K Financial Statement

#000182912623002253 Filed on March 24, 2023

Income Statement

Concept	2023 Q1	2022 Q4	2022
Revenue	$144.9K	$70.00K	$659.8K
YoY Change	-38.6%
Cost Of Revenue	$134.6K	$260.0K	$716.1K
YoY Change	-16.71%	23.81%	32.02%
Gross Profit	$10.29K	-$200.0K	-$56.29K
YoY Change	-86.17%	-385.71%	-137.97%
Gross Profit Margin	7.1%	-285.71%	-8.53%
Selling, General & Admin	$1.253M	$1.550M	$4.856M
YoY Change	5.14%	11.51%	53.8%
% of Gross Profit	12176.36%
Research & Development	$151.2K	$130.0K	$524.7K
YoY Change	322.18%	160.0%	508.26%
% of Gross Profit	1468.94%
Depreciation & Amortization	$10.31K	$10.00K	$22.10K
YoY Change	158.77%		4337.95%
% of Gross Profit	100.16%
Operating Expenses	$1.439M	$1.680M	$5.520M
YoY Change	13.99%	15.86%	64.62%
Operating Profit	-$1.429M	-$1.880M	-$5.577M
YoY Change	20.26%	36.23%	73.99%
Interest Expense	$1.939K	$0.00	$105.2K
YoY Change	-89.15%	-100.0%	166.71%
% of Operating Profit
Other Income/Expense, Net	-$1.863K	$0.00	-$105.2K
YoY Change	-89.86%
Pretax Income	-$1.430M	-$1.880M	-$5.680M
YoY Change	18.18%	35.25%	75.31%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$1.431M	-$1.880M	-$5.682M
YoY Change	18.59%	35.25%	75.12%
Net Earnings / Revenue	-987.3%	-2685.71%	-861.16%
Basic Earnings Per Share	-$0.19		-$0.87
Diluted Earnings Per Share	-$0.19	-$0.26	-$0.87
COMMON SHARES
Basic Shares Outstanding	7.716M shares	7.307M shares
Diluted Shares Outstanding	7.569M shares		6.529M shares

Balance Sheet

Concept	2023 Q1	2022 Q4	2022
SHORT-TERM ASSETS
Cash & Short-Term Investments	$3.450M	$3.590M	$3.590M
YoY Change		4387.5%	4387.5%
Cash & Equivalents	$3.450M	$3.591M	$3.590M
Short-Term Investments
Other Short-Term Assets	$36.24K	$36.24K	$450.0K
YoY Change		2382.19%	87.5%
Inventory	$743.1K	$94.70K	$90.00K
Prepaid Expenses	$185.3K	$210.7K
Receivables	$127.6K	$110.3K	$110.0K
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$4.542M	$4.241M	$4.240M
YoY Change		558.16%	562.5%
LONG-TERM ASSETS
Property, Plant & Equipment	$137.6K	$119.7K	$120.0K
YoY Change		490.34%	500.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$82.72K	$81.78K	$80.00K
YoY Change
Total Long-Term Assets	$570.8K	$449.2K	$450.0K
YoY Change		149.54%	150.0%
TOTAL ASSETS
Total Short-Term Assets	$4.542M	$4.241M	$4.240M
Total Long-Term Assets	$570.8K	$449.2K	$450.0K
Total Assets	$5.113M	$4.690M	$4.690M
YoY Change		468.94%	471.95%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$290.0K	$280.0K	$280.0K
YoY Change		64.71%	64.71%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$60.00K	$60.00K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$504.6K	$600.0K	$600.0K
YoY Change		-2.72%	-3.23%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$60.00K	$70.00K	$70.00K
YoY Change
Total Long-Term Liabilities	$60.00K	$70.00K	$70.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$504.6K	$600.0K	$600.0K
Total Long-Term Liabilities	$60.00K	$70.00K	$70.00K
Total Liabilities	$562.6K	$665.5K	$670.0K
YoY Change		7.89%	8.06%
SHAREHOLDERS EQUITY
Retained Earnings	-$11.74M	-$10.31M
YoY Change		122.87%
Common Stock	$77.00	$73.00
YoY Change		21.67%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$4.550M	$4.024M	$4.020M
YoY Change
Total Liabilities & Shareholders Equity	$5.113M	$4.690M	$4.690M
YoY Change		468.94%	471.95%

Cashflow Statement

Concept	2023 Q1	2022 Q4	2022
OPERATING ACTIVITIES
Net Income	-$1.431M	-$1.880M	-$5.682M
YoY Change	18.59%	35.25%	75.12%
Depreciation, Depletion And Amortization	$10.31K	$10.00K	$22.10K
YoY Change	158.77%		4337.95%
Cash From Operating Activities	-$1.427M	-$1.220M	-$3.224M
YoY Change	126.21%	-1320.0%	-3324.42%
INVESTING ACTIVITIES
Capital Expenditures	$28.14K	$60.00K	$121.6K
YoY Change	-12.37%	100.0%	484.93%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$137.0K	-$60.00K	-$220.0K
YoY Change	65.69%	100.0%	85.68%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$1.423M	-90.00K	$6.956M
YoY Change	110.61%	-120.0%	402.11%
NET CHANGE
Cash From Operating Activities	-$1.427M	-1.220M	-$3.224M
Cash From Investing Activities	-$137.0K	-60.00K	-$220.0K
Cash From Financing Activities	$1.423M	-90.00K	$6.956M
Net Change In Cash	-$141.3K	-1.370M	$3.511M
YoY Change	272.03%	-1470.0%	3411.38%
FREE CASH FLOW
Cash From Operating Activities	-$1.427M	-$1.220M	-$3.224M
Capital Expenditures	$28.14K	$60.00K	$121.6K
Free Cash Flow	-$1.455M	-$1.280M	-$3.346M
YoY Change	119.5%	-1928.57%	-4323.76%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001808377
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts		usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2021Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent		usd
CY2021Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable		usd
CY2022	LUCY	Writeoff Of Uncollectible Stock Subscription Receivable WriteoffOfUncollectibleStockSubscriptionReceivable		usd
CY2021	LUCY	Contract Assets And Liabilities ContractAssetsAndLiabilities		usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	LUCY	Payment Of Deferred Offering Cost PaymentOfDeferredOfferingCost		usd
CY2021	LUCY	Collection Of Stock Subscription Receivable CollectionOfStockSubscriptionReceivable		usd
CY2021	LUCY	Writeoff Of Uncollectible Stock Subscription Receivables WriteoffOfUncollectibleStockSubscriptionReceivables		usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-41392
CY2022	dei	Entity Registrant Name EntityRegistrantName	INNOVATIVE EYEWEAR, INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	FL
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	84-2794274
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	11900 Biscayne Blvd.
CY2022	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 630
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	North Miami
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	FL
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	33181
CY2022	dei	City Area Code CityAreaCode	(954)
CY2022	dei	Local Phone Number LocalPhoneNumber	826-0329
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	0	usd
CY2023Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7715757	shares
CY2022	dei	Auditor Name AuditorName	Cherry Bekaert LLP
CY2022	dei	Auditor Location AuditorLocation	Tampa, Florida
CY2022	dei	Auditor Firm AuditorFirmId	677
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3591109	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	79727	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	92646	usd
CY2021Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	0	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	110258	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	43394	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	210673	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	68381	usd
CY2021Q4	us-gaap	Deferred Offering Costs DeferredOfferingCosts	111149	usd
CY2022Q4	LUCY	Inventory Prepayment InventoryPrepayment	197750	usd
CY2021Q4	LUCY	Inventory Prepayment InventoryPrepayment	64715	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	94701	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	275501	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	36240	usd
CY2021Q4	us-gaap	Other Assets Current OtherAssetsCurrent	1460	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	4240731	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	644327	usd
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	137557	usd
CY2021Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	87306	usd
CY2022Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	110073	usd
CY2021Q4	us-gaap	Capitalized Computer Software Net CapitalizedComputerSoftwareNet	72400	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119744	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20284	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	81779	usd
CY2022Q4	us-gaap	Assets Assets	4689884	usd
CY2021Q4	us-gaap	Assets Assets	824317	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	275660	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	167050	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	30000	usd
CY2022Q4	LUCY	Due To Parent And Affiliates DueToParentAndAffiliates	232989	usd
CY2021Q4	LUCY	Due To Parent And Affiliates DueToParentAndAffiliates	160722	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	61356	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	289029	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	600005	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	616801	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	65450	usd
CY2022Q4	us-gaap	Liabilities Liabilities	665455	usd
CY2021Q4	us-gaap	Liabilities Liabilities	616801	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.00001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7307157	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7307157	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6060187	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6060187	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	73	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	60	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	14330343	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4842836	usd
CY2021Q4	us-gaap	Stockholders Equity Note Subscriptions Receivable StockholdersEquityNoteSubscriptionsReceivable	11226	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-10305987	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4624154	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4024429	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	207516	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	4689884	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	824317	usd
CY2022	us-gaap	Revenues Revenues	659788	usd
CY2021	us-gaap	Revenues Revenues	690670	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	716077	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	542416	usd
CY2022	us-gaap	Gross Profit GrossProfit	-56289	usd
CY2021	us-gaap	Gross Profit GrossProfit	148254	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2796669	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1386079	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2059012	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	1771012	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	524692	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	86261	usd
CY2022	us-gaap	Management Fee Expense ManagementFeeExpense	140000	usd
CY2021	us-gaap	Management Fee Expense ManagementFeeExpense	109975	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	5520373	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	3353327	usd
CY2022	us-gaap	Interest Expense InterestExpense	105171	usd
CY2021	us-gaap	Interest Expense InterestExpense	39433	usd
CY2022	us-gaap	Profit Loss ProfitLoss	-5681833	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-3244506	usd
CY2022	LUCY	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	6528959	shares
CY2021	LUCY	Weighted Average Number Of Shares Outstanding WeightedAverageNumberOfSharesOutstanding	5245622	shares
CY2022	LUCY	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.87
CY2021	LUCY	Earnings Per Shares Basic And Diluted EarningsPerSharesBasicAndDiluted	-0.62
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	207516	usd
CY2022	LUCY	Collection Of Stock Subscriptions Receivable CollectionOfStockSubscriptionsReceivable	6684	usd
CY2022	LUCY	Shares Issued For Conversion Of Related Party Convertible Note SharesIssuedForConversionOfRelatedPartyConvertibleNote	2002280	usd
CY2022	LUCY	Initial Public Offering See Note InitialPublicOfferingSeeNote	6015918	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1473864	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5681833	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	4024429	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-554837	usd
CY2021	LUCY	Shares Issued For Conversion Of Related Party Convertible Note SharesIssuedForConversionOfRelatedPartyConvertibleNote	2179772	usd
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	437968	usd
CY2021	LUCY	Collection Of Stock Subscriptions Receivable CollectionOfStockSubscriptionsReceivable	54184	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1334935	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3244506	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	207516	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-5681833	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-3244506	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10466	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7179	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	22101	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	498	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	105171	usd
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense	1251	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	1473864	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	1334935	usd
CY2022	LUCY	Expenses Paid By Parent And Affiliates ExpensesPaidByParentAndAffiliates	960362	usd
CY2021	LUCY	Expenses Paid By Parent And Affiliates ExpensesPaidByParentAndAffiliates	867618	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	116230	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	-0	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	183094	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	43394	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	67951	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	157536	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	142292	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	43381	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-47765	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	250436	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-1460	usd
CY2021	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	1460	usd
CY2022	LUCY	Contract Assets And Liabilities ContractAssetsAndLiabilities	22569	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3224418	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1214160	usd
CY2022	LUCY	Payment To Acquire Patent Costs PaymentToAcquirePatentCosts	60717	usd
CY2021	LUCY	Payment To Acquire Patent Costs PaymentToAcquirePatentCosts	25272	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	121561	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	20782	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	37673	usd
CY2021	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	72400	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-219951	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-118454	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	6127067	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	492152	usd
CY2021	LUCY	Payment Of Deferred Offering Cost PaymentOfDeferredOfferingCost	111149	usd
CY2022	LUCY	Collection Of Stock Subscription Receivable CollectionOfStockSubscriptionReceivable	6684	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1475000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	1061500	usd
CY2022	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	653000	usd
CY2021	us-gaap	Repayments Of Convertible Debt RepaymentsOfConvertibleDebt	57185	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6955751	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1385318	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	3511382	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	52704	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79727	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	27023	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	3591109	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	79727	usd
CY2022	LUCY	Expenses Paid For By Parent Reported As Increase In Due To Parent And Affiliates And Related Party Convertible Debt ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt	960362	usd
CY2021	LUCY	Expenses Paid For By Parent Reported As Increase In Due To Parent And Affiliates And Related Party Convertible Debt ExpensesPaidForByParentReportedAsIncreaseInDueToParentAndAffiliatesAndRelatedPartyConvertibleDebt	867618	usd
CY2022	LUCY	Writeoff Of Uncollectible Stock Subscription Receivables WriteoffOfUncollectibleStockSubscriptionReceivables	-4542	usd
CY2022	us-gaap	Nature Of Operations NatureOfOperations	<p id="xdx_80B_eus-gaap--NatureOfOperations_z3GxVlqEeT88" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_826_zpPy4FpIYY7i">GENERAL INFORMATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Innovative Eyewear, Inc. (the “Company,” “us,” “we,” or “our”) is a corporation organized under the laws of the State of Florida that develops and sells cutting-edge eyeglasses and sunglasses, which are designed to allow our customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. The Company was founded by Lucyd Ltd. (the “Parent” or “Lucyd”), a portfolio company of Tekcapital Plc through Tekcapital Europe, Ltd. (collectively, the “Parent and Affiliates”), which owned approximately 71% of our issued and outstanding shares of common stock as of December 31, 2022. Innovative Eyewear licensed the exclusive rights to the Lucyd<sup>®</sup> brand from Lucyd Ltd., which includes the exclusive use of all of Lucyd’s intellectual property, including our main product, Lucyd Lyte<sup>®</sup> glasses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_84A_eus-gaap--UseOfEstimates_zQqeUvf2Mwbb" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_869_zuu18hnQD8Rl" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Use of Estimates</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates, particularly given the significant economic disruptions and uncertainties associated with the ongoing economic environment, including potential supply chain constraints.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	116230	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	0	usd
CY2022Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	6413441	usd
CY2022Q4	LUCY	State Net Operating Loss Carryforwards StateNetOperatingLossCarryforwards	3653332	usd
CY2022Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2021Q4	us-gaap	Liability For Uncertain Tax Positions Current LiabilityForUncertainTaxPositionsCurrent	0	usd
CY2022Q4	LUCY	Inventory Prepayment InventoryPrepayment	197750	usd
CY2021Q4	LUCY	Inventory Prepayment InventoryPrepayment	64715	usd
CY2022	us-gaap	Depreciation Depreciation	22100	usd
CY2021	us-gaap	Depreciation Depreciation	500	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	142343	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	20782	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22599	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	498	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	119744	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	20284	usd
CY2022Q3	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	500002	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zl3QU4HMsXN1" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span id="xdx_860_zNrYKjMesJUf" style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Concentrations of Credit Risk</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and accounts receivable. The Company limits its credit risk with respect to cash by maintaining cash balances with high quality financial institutions. At times, the Company’s cash balances may exceed federally insured limits. Concentrations of credit risk with respect to accounts receivable are considered minimal due to collection history.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022Q4	LUCY	Allowance For Sales Returns AllowanceForSalesReturns	24897	usd
CY2021Q4	LUCY	Allowance For Sales Returns AllowanceForSalesReturns	22266	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1193185	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	681346	usd
CY2022	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	35149	usd
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	110647	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-1228334	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-791993	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	610530	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	359032	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	122133	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	6757	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	1346823	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	534771	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	81911	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Domestic DeferredTaxAssetsOperatingLossCarryforwardsDomestic	110647	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	2161397	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	1011207	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2161397	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	1011207	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	156196	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	95480	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-18639	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	-8174	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	137557	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	87306	usd
CY2022	us-gaap	Adjustment For Amortization AdjustmentForAmortization	10500	usd
CY2021	us-gaap	Adjustment For Amortization AdjustmentForAmortization	7200	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	11500	usd
CY2022Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	61356	usd
CY2021Q4	us-gaap	Convertible Debt Current ConvertibleDebtCurrent	289029	usd
CY2022Q2	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	778500	usd
CY2022Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	778500	shares
CY2022Q2	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	1.00
CY2022Q3	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	140449	shares
CY2022Q3	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	3.56
CY2022Q4	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	901271	usd
CY2022Q4	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	253166	shares
CY2022Q4	us-gaap	Debt Instrument Convertible Conversion Price1 DebtInstrumentConvertibleConversionPrice1	3.56
CY2022	LUCY	Base Term BaseTerm	P10Y
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	36750	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	161210	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	356000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	654000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	930000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	7200000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	9337960	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	15000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1124043	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1687500	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	0	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.84
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.00
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	645000	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	3.23
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1687500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.61
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2332500	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	1.87
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	395269	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.61
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2332500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.61
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2332500	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2.18
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	1198577	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P1Y8M4D
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P1Y9M14D
CY2022Q4	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized	1409958	usd
CY2022	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1 EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1	P1Y4M28D
CY2022	us-gaap	Profit Loss ProfitLoss	-5681833	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-3244506	usd
CY2022	LUCY	Weightedaverage Number Of Common Shares WeightedaverageNumberOfCommonShares	6528959	shares
CY2021	LUCY	Weightedaverage Number Of Common Shares WeightedaverageNumberOfCommonShares	5245622	shares
CY2022	LUCY	Basic And Diluted Net Income Loss Per Common Share BasicAndDilutedNetIncomeLossPerCommonShare	-0.87
CY2021	LUCY	Basic And Diluted Net Income Loss Per Common Share BasicAndDilutedNetIncomeLossPerCommonShare	-0.62

Files In Submission

Name	View Source	Status
0001829126-23-002253-index-headers.html	Edgar Link	pending
0001829126-23-002253-index.html	Edgar Link	pending
0001829126-23-002253.txt	Edgar Link	pending
0001829126-23-002253-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
innovativeeye_10k.htm	Edgar Link	pending
innovativeeye_ex19.htm	Edgar Link	pending
innovativeeye_ex23-1.htm	Edgar Link	pending
innovativeeye_ex31-1.htm	Edgar Link	pending
innovativeeye_ex31-2.htm	Edgar Link	pending
innovativeeye_ex32-1.htm	Edgar Link	pending
innovativeeye_ex32-2.htm	Edgar Link	pending
lucy-20221231.xsd	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
lucy-20221231_cal.xml	Edgar Link	unprocessable
lucy-20221231_lab.xml	Edgar Link	unprocessable
lucy-20221231_pre.xml	Edgar Link	unprocessable
innovativeeye_10k_htm.xml	Edgar Link	completed
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
lucy-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$LUCY
Innovative Eyewear Inc Stock $lucy

2023 Q1 Form 10-K Financial Statement

#000182912623002253 Filed on March 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCY Innovative Eyewear Inc Stock $lucy

2023 Q1 Form 10-K Financial Statement

#000182912623002253 Filed on March 24, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$LUCY
Innovative Eyewear Inc Stock $lucy